鸚鵡螺體育 NLS 深 滬
等待開盤 03-26 09:30:00 美东时间
0.8204
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 0.8204
- 總市值 2960.82万
- 52周最高 2.17
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 0.641
- 委 比 0.00%
- 總股本 3609.00万
- 歷史最高 31.38
- 量 比 0
- 振 幅 0.00%
- 歷史最低 0.641
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform
Baylor College of Medicine joins Nautilus Biotechnology's Early Access Program to develop a computational multi-omics toolkit for high-resolution cancer isoform analysis. The NIH-funded project, led by Baylor professors Bing Zhang and Yongchao Dou, aims to improve protein isoform detection using Nautilus' single-molecule proteomics platform. Nautilus' Voyager Platform, which employs Iterative Mapping, enables precise protein and proteoform quanti...
03-18 12:00
Nautilus Resources LLC Disposes of AleAnna Inc. Class A Common Shares
Nautilus Resources LLC Disposes of AleAnna Inc. Class A Common Shares C. John Wilder Jr., a 10% beneficial owner of AleAnna Inc., reported disposing of shares of the company’s Class A common stock. The Form 4 was filed by C. John Wilder Jr. and Nautilus Resources LLC, along with other reporting bene
03-04 19:26
Nautilus Biotechnology names Amber Faust vice president of sales
Nautilus Biotechnology names Amber Faust vice president of sales Nautilus Biotechnology Inc. appointed Amber Faust as Vice President of Sales. Faust, a proteomics commercial leader with prior roles at Olink Proteomics, SomaLogic, and Waters Corporation, will lead sales efforts tied to the Nautilus V
03-02 21:03
Nautilus Biotechnolgy Charts Cash-Backed Path to 2027
Nautilus Biotechnolgy, Inc. (($NAUT)) has held its Q4 earnings call. Read on fo...
02-27 08:24
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Curanex Pharmaceuticals (NASDAQ:CURX) shares moved upwards by 57.7% to...
02-27 01:05
Nautilus Biotechnology shares are trading lower. The company reported Q4 financial results.
Nautilus Biotechnology shares are trading lower. The company reported Q4 financ...
02-26 23:41
Nautilus Biotechnology Q4 EPS $(0.11) Beats $(0.14) Estimate
Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.14) by 21.43 percent. This is a 21.43 percent increase over losses of $(0.14) per share
02-26 19:11
Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference
Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a pioneer in single-molecule protein analysis, announced its participation in the TD Cowen 46th Annual Health Care Conference. The company's management will engage in a fireside chat on March 2, 2026, at 10:30 a.m. ET. A live and archived webcast will be available on the company's website. Nautilus, headquartered in Seattle with R&D operations in San Carlos, California, aims to revolutionize proteomics...
02-19 21:05
Beta Technologies Stock Soars After Amazon Reveals Stake
Beta Technologies shares are rising in extended trading Tuesday after Amazon.com Inc (NASDAQ:AMZN) discloses a stake in the company.
02-11 06:25
